Back to User profile » Dr Antonia Sampol
Papers published by Dr Antonia Sampol:
Multiclonal Profiling of FLT3-ITD in AML Using MinION Sequencing: A Tailored Clustering Approach to Enhance Subclonal Detection
Martínez-Serra J, Alonso-Carballo A, Horrillo Á, Gómez P, Vögler O, Gutiérrez A, Sampol A
OncoTargets and Therapy 2025, 18:811-820
Published Date: 19 July 2025
Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
Delgado Sánchez O, Gutiérrez A, do Pazo F, Ginés J, Martorell C, Boyeras B, Bento L, Garcia-Recio M, Sampol A
ClinicoEconomics and Outcomes Research 2019, 11:695-701
Published Date: 18 November 2019
Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
Garcia-Recio M, Martinez-Serra J, Mestre F, Bento L, Gines J, Ramos R, Daumal J, López P, Sampol A, Gutierrez A
OncoTargets and Therapy 2018, 11:6599-6603
Published Date: 8 October 2018
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report
Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A
OncoTargets and Therapy 2016, 9:5507-5511
Published Date: 7 September 2016
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
Gutierrez A, Rodriguez J, Martinez-Serra J, Gines J, Paredes P, Garcia F, Vercher J, Balanzat J, del Campo R, Galan P, Morey M, Sampol A, Novo A, Bento L, García L, Bargay J, Besalduch J
OncoTargets and Therapy 2014, 7:2093-2100
Published Date: 13 November 2014